THE HOTTEST SECTOR IS MADDENING

I can’t understand what the hell these companies do!

For the life of me, I read through their statements and listened to their conference calls; but it’s all mumbo gumbo–frankly. Biotechs are nothing more, or less, than high stake gambles. The scientists assigned to these companies couldn’t care less about share prices and don’t mind sending in drugs for FDA denials, just so they could fine tune it for approval later. Bear in mind, this coming from a man who owns a large position in RPTP should come across as “all the more credible” and entirely “genuine.”

I like CLDX, CGIX (thin), RGLS, ENZY and maybe a little ONCY.

If you want to gamble a lot, have a look at AMRN. One of their stupid drugs were cast aside by the FDA last year and is up for review RIGHT NOW. The FDA promised to give them an answer by 1/15/13. That means: the stock is either going to crater or soar within two trading days.

GOOD LUCK!

The truth is, there are many biotech stocks that I want to buy now, since they’re all running, looking all cool and stuff, showing their swagger with extreme imprudence. But I had to check myself, not once, but twice. I have enough tied up in RPTP and if I took my cash and bought another biotech hand grenade, I’d be placing myself into the hurt locker, without any means to detonate the device. I’d just be sitting there, like a paradiddle, waiting to explode.